Diuretic Dosing for Ascites in Cirrhosis
Start spironolactone 100 mg once daily in the morning and furosemide 40 mg once daily simultaneously, maintaining a 100:40 ratio, and titrate both upward together every 3-5 days based on weight loss, urine output, and laboratory monitoring until achieving target weight loss of 0.5 kg/day (1 kg/day if peripheral edema present). 1, 2
Starting Doses
The evidence strongly supports combined therapy from the outset rather than sequential addition:
- Spironolactone: 100 mg once daily (morning dosing to avoid nocturia due to long half-life) 1, 2
- Furosemide: 40 mg once daily 1, 2
- Maintain the 40:100 ratio (furosemide:spironolactone) throughout titration to preserve normokalemia 1
The 2025 AGA guideline emphasizes that combined therapy outperforms monotherapy or sequential use by enhancing natriuresis while maintaining potassium balance 1. While one older study suggested spironolactone monotherapy may work for first-episode ascites 3, the most recent high-quality guidelines prioritize combination therapy for superior efficacy 1.
Titration Schedule
Increase doses every 3-5 days if inadequate response, maintaining the 40:100 ratio 1, 2:
- Spironolactone: 100 mg → 200 mg → 300 mg → maximum 400 mg/day
- Furosemide: 40 mg → 80 mg → 120 mg → maximum 160 mg/day
Important caveat: Spironolactone has a long half-life—full effects of dose changes may not appear for 72 hours, so wait at least 3 days between adjustments 2.
Target Weight Loss
- Without peripheral edema: 0.5 kg/day maximum 1, 2
- With peripheral edema: 1 kg/day (no upper limit) 1, 2
Patients should weigh themselves daily at the same time 1.
Monitoring Parameters
Initial Monitoring (First Week)
- Electrolytes (Na, K, Cl) and renal function (creatinine, BUN): Within 1 week of initiation 4
- Weight: Daily 1
- Blood pressure: Regularly to detect hypotension 4
Ongoing Monitoring
- Electrolytes and renal function: After each dose titration and regularly thereafter 4
- 24-hour urine sodium (or spot urine Na/K ratio): To assess dietary compliance and diuretic response 2
Additional Laboratory Monitoring
- Magnesium, calcium, uric acid, glucose: Periodically, as spironolactone can cause multiple metabolic derangements 4
Critical Pitfalls to Avoid
Hyperkalemia risk (most serious complication): More frequent monitoring needed if:
Excessive diuresis: Can cause symptomatic hypotension, dehydration, and acute kidney injury 4. Titrate to lowest effective dose 1.
Gynecomastia: Dose-dependent side effect occurring in ~9% of patients, onset 1 month to >1 year 4. If intolerable, switch to amiloride or eplerenone (though less effective) 2, 5.
Hyponatremia: High doses of both diuretics (furosemide 250-500 mg, spironolactone 50-100 mg) independently increase risk 6. Fluid restriction only needed if significant hyponatremia develops 1, 2.
Hospitalized patients with cirrhosis: Always initiate therapy in hospital setting and titrate slowly due to unpredictable response 4.
Dietary Management
- Sodium restriction: <2000 mg (90 mmol) per day 1, 2
- Formal dietitian referral strongly recommended 1, 2
- Maintain adequate nutrition: ≥35 kcal/kg/day, protein 1.2-1.5 g/kg/day 1
- No fluid restriction unless hyponatremia present 1, 2
Definition of Refractory Ascites
Ascites unresponsive to maximum doses (spironolactone 400 mg + furosemide 160 mg) with sodium restriction, or inability to reach these doses due to complications 2, 7. This occurs in ~10% of patients and requires alternative therapies (serial paracentesis, TIPS, transplant evaluation) 8, 7.